Zeo ScientifiX, Inc. (OTCPK: ZEOX)
Health Care · Biotechnology · US
$0.91
-23.11% today · -52.0% 1Y
Zeo ScientifiX, Inc. (OTCPK: ZEOX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.14M and employs 33 people.
Over the last twelve months the share price has lost 52.0%, trading between 0.84 and 2.99.
Tweenvest scores Zeo ScientifiX, Inc. across four factors: quality 36/100, value 28/100, growth 69/100. Its strongest factor is growth.
ZEOX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.14M
- Revenue (TTM)
- $6.99M
- P/E
- —
- EPS
- -0.56
- Dividend yield
- —
- Beta (5Y)
- 1.74
- 52-week high
- $2.99
- 52-week low
- $0.84
- Avg volume (3M)
- —
- Shares outstanding
- 7.84M
- Employees
- 33
- Next earnings
- —
About Zeo ScientifiX, Inc.
Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.
- ISIN
- US68621D2062
- Founded
- 2011
- Listed since
- Mar 1, 2016
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aprea Therapeutics, Inc.NasdaqCM: APRE | $7.36M | $0.58 | -3.34% |
| Exicure, Inc.NasdaqCM: XCUR | $7.33M | $1.12 | +6.67% |
| Oncodesign Precision Medicine Société anonymeENXTPA: ALOPM | $7.30M | €0.34 | +3.33% |
| Prostatype Genomics AB (publ)OM: PROGEN | $7.26M | Skr0.10 | +13.29% |
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $7.00M | $0.22 | -28.47% |
| Rakovina Therapeutics Inc.TSXV: RKV | $6.93M | CA$0.22 | -2.22% |
| Skye Bioscience, Inc.NasdaqCM: SKYE | $6.86M | $1.55 | -8.28% |
| CollPlant Biotechnologies Ltd.NasdaqCM: CLGN | $6.85M | $3.63 | +3.28% |
Figures last refreshed Oct 18, 2026.